Pietzner, Klaus <br/><br/>
Re-challenge with catumaxomab in patients with malignant ascites: results from the SECIMAS study.  [electronic resource] 

 -  Medical oncology (Northwood, London, England)  Dec 2014 
 - 308 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1559-131X 
<br/><br/><label>Standard No.: </label>10.1007/s12032-014-0308-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Bispecific--administration & dosage<br/>Ascites--drug therapy<br/>Female<br/>Humans<br/>Infusions, Parenteral<br/>Male<br/>Middle Aged<br/>Peritoneal Neoplasms--drug therapy<br/>Quality of Life<br/>Survival Analysis<br/>Treatment Outcome